CXCL10 and systemic sclerosis: Indeed, we could speculate that lowering serum CXCL10 might be of particular interest, considering that higher circulating CXCL10 is associated with a shift from UCTD at risk for SSc, so far referred to as VEDOSS, to defined SSc, as previously addressed [14,16].